EnBio Holdings Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Yoshikazu Nakamura
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.9yrs |
| CEO ownership | 5.3% |
| Management average tenure | no data |
| Board average tenure | 5.4yrs |
Recent management updates
Recent updates
EnBio Holdings (TSE:6092) Has Affirmed Its Dividend Of ¥8.00
Mar 13
EnBio Holdings (TSE:6092) Is Due To Pay A Dividend Of ¥8.00
Feb 20EnBio Holdings (TSE:6092) Has Announced A Dividend Of ¥8.00
Jan 14EnBio Holdings (TSE:6092) Is Paying Out A Dividend Of ¥8.00
Dec 14EnBio Holdings (TSE:6092) Has Affirmed Its Dividend Of ¥8.00
Nov 16Returns On Capital At EnBio Holdings (TSE:6092) Have Stalled
Aug 07CEO
Yoshikazu Nakamura (51 yo)
Mr. Yoshikazu Nakamura is Independent Outside Director of User Local, Inc. since September 2024 and was External Auditor. He is President at EnBio Holdings, Inc. since June 2023. He serves as an Independen...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & Representative Director | 20.9yrs | no data | 5.35% ¥ 251.4m | |
| Independent Outside Director | 1.9yrs | no data | 0.12% ¥ 5.8m | |
| Chairman of the Board | 17.3yrs | no data | 6.13% ¥ 288.4m | |
| Independent Outside Director | 8.9yrs | no data | 0.0012% ¥ 58.3k | |
| Independent Outside Director | 1.9yrs | no data | 2.47% ¥ 116.4m | |
| Independent Outside Director | 1.9yrs | no data | 0.19% ¥ 8.7m | |
| Director | 5.9yrs | no data | 0.19% ¥ 9.0m | |
| Director | 5.9yrs | no data | 0.17% ¥ 8.2m | |
| Independent Outside Director | 4.9yrs | no data | 0.012% ¥ 581.8k | |
| Independent Outside Director | 1.9yrs | no data | no data |
Experienced Board: 6092's board of directors are considered experienced (5.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/24 20:56 |
| End of Day Share Price | 2025/05/23 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
EnBio Holdings, Inc is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yoko Mizoguchi | Ichiyoshi Research Institute Inc. |
| Eiji Tomaru | Mizuho Securities Co., Ltd. |